Listar por agencia financiadora "Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd)"
Mostrando ítems 1-1 de 1
-
Artículo
Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells
(Springer Nature, 2020)Sorafenib and Regorafenib are the recommended first- and second-line therapies in patients with advanced hepatocellular ...